Pharmacotherapeutics with special reference to Hridroga in relation to Cardiac Disorders

Hridaya is mentioned as Marma sthana in Ayurveda. According to world heart report 2023 more than half a billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths close to a third of all deaths globally and an overall increase on the estimated 121 million CVD deaths. In Ayurveda upmost importance is given for Hridaya and for Hridroga chikitsa. Hence an attempt is made to ease the Ayurvedic approach in treatment of Cardiac disorders. In view of the increasing incidence of cardiac disorders in the present times this aspect assumes added importance. This work sheds light on the pharmacotherapeutic aspect of Hridroga from Dravyaguna point of view. This article includes the selection of Dravya, Ekaladravya Prayoga along with its research works supporting their cardioprotective activity, Gana/Varga attributed with Hridya Karma and Amayika Prayoga in different Hridroga, so that It can aid in prevention and management of Hridroga with precise drug.